Literature DB >> 8334439

Human peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lung.

C J Omiecinski1, L Aicher, R Holubkov, H Checkoway.   

Abstract

In this study, we have applied an improved assay for the determination of microsomal epoxide hydrolase activity to assess enzymatic levels in human lung, liver, and blood lymphocytes. The assay is fluorescence-based and monitors the epoxide hydrolase-mediated conversion of (+/-)-benzo[a]pyrene-4,5-epoxide to (+/-)-trans-benzo[a]pyrene-4,5-dihydrodiol, using a high pressure liquid chromatography separation system. Approximately a 40-fold range in microsomal epoxide hydrolase activities was detected in blood lymphocytes collected from 70 individual donors. In 38 individuals who were sampled twice after a 3-month interval, the repeatability of an individual's lymphocyte epoxide hydrolase activity was highly correlated (r = 0.80, p < 0.02). In addition, within the same individual there appeared to be a strong correlation between lymphocyte and liver epoxide hydrolase activity (r = 0.92, p = 0.02), and some correlation between liver and lung activity (r = 0.58, p = 0.05). Activities were assessed in lymphocytes from a styrene-exposed worker population but no significant associations between blood concentrations of styrene and epoxide hydrolase activity levels were observed. Neither were any correlations detected in these workers between epoxide hydrolase activities and age, years on the job, alcohol consumption, sex, or smoking status. The results of our study suggest that blood lymphocytes are a useful sentinel cell for epoxide hydrolase activity determinations in individuals, as these measures are relatively stable over time and appear to reflect activity levels in other target organs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8334439     DOI: 10.1097/00008571-199306000-00005

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  20 in total

1.  EPHX1 A139G polymorphism and lung cancer risk: a meta-analysis.

Authors:  Hong Liu; Hai-Yan Li; Hong-Jie Chen; Yong-Jie Huang; Shao Zhang; Jing Wang
Journal:  Tumour Biol       Date:  2012-10-09

2.  Association of the genetic polymorphism of EPHX1 and EPHX2 with the susceptibility to chronic benzene poisoning.

Authors:  Pin Sun; Zhongbin Zhang; Fen Wu; Junxiang Wan; Xibeng Jin; Zhaolin Xia
Journal:  Front Med China       Date:  2007-07

3.  Genetic analysis of microsomal epoxide hydrolase gene and its association with lung cancer risk.

Authors:  J Y Park; L Chen; A Elahi; P Lazarus; M S Tockman
Journal:  Eur J Cancer Prev       Date:  2005-06       Impact factor: 2.497

4.  EPHX1 rs2234922 polymorphism and lung cancer susceptibility in Asian populations: a meta-analysis.

Authors:  Xuefang Xu; Hongxia Hua; Bing Fan; Qing Sun; Xuedan Guo; Jiawei Zhang
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

5.  Neurobehavioural changes and persistence of complaints in workers exposed to styrene in a polyester boat building plant: influence of exposure characteristics and microsomal epoxide hydrolase phenotype.

Authors:  M K Viaene; W Pauwels; H Veulemans; H A Roels; R Masschelein
Journal:  Occup Environ Med       Date:  2001-02       Impact factor: 4.402

6.  Alternative promoters determine tissue-specific expression profiles of the human microsomal epoxide hydrolase gene (EPHX1).

Authors:  Shun-Hsin Liang; Christopher Hassett; Curtis J Omiecinski
Journal:  Mol Pharmacol       Date:  2004-10-01       Impact factor: 4.436

Review 7.  Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis.

Authors:  L M Bull; D L White; M Bray; Z Nurgalieva; H B El-Serag
Journal:  Dis Esophagus       Date:  2009-02-13       Impact factor: 3.429

8.  Lymphocyte microsomal epoxide hydrolase in patients on carbamazepine therapy.

Authors:  M Pirmohamed; R Allott; V J Green; N R Kitteringham; D Chadwick; B K Park
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335

9.  The expression of human microsomal epoxide hydrolase is predominantly driven by a genetically polymorphic far upstream promoter.

Authors:  Xi Yang; Shun-Hsin Liang; Denise M Weyant; Philip Lazarus; Carla J Gallagher; Curtis J Omiecinski
Journal:  J Pharmacol Exp Ther       Date:  2009-04-13       Impact factor: 4.030

10.  Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants.

Authors:  C Hassett; L Aicher; J S Sidhu; C J Omiecinski
Journal:  Hum Mol Genet       Date:  1994-03       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.